CU24291B1 - Nuevo procedimiento de síntesis de la agomelatina - Google Patents

Nuevo procedimiento de síntesis de la agomelatina

Info

Publication number
CU24291B1
CU24291B1 CUP2013000087A CU20130087A CU24291B1 CU 24291 B1 CU24291 B1 CU 24291B1 CU P2013000087 A CUP2013000087 A CU P2013000087A CU 20130087 A CU20130087 A CU 20130087A CU 24291 B1 CU24291 B1 CU 24291B1
Authority
CU
Cuba
Prior art keywords
synthesis procedure
new
agomelatine synthesis
new agomelatine
formula
Prior art date
Application number
CUP2013000087A
Other languages
English (en)
Spanish (es)
Other versions
CU20130087A7 (es
Inventor
Mehdi Boumediene
Béatrice Sire
Samir Zard
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44121614&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CU24291(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Servier Lab filed Critical Servier Lab
Publication of CU20130087A7 publication Critical patent/CU20130087A7/es
Publication of CU24291B1 publication Critical patent/CU24291B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/14—Preparation of carboxylic acid amides by formation of carboxamide groups together with reactions not involving the carboxamide groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/10—Preparation of carboxylic acid amides from compounds not provided for in groups C07C231/02 - C07C231/08
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pain & Pain Management (AREA)
  • Reproductive Health (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Catalysts (AREA)
CUP2013000087A 2011-01-05 2012-01-04 Nuevo procedimiento de síntesis de la agomelatina CU24291B1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1100023A FR2970001B1 (fr) 2011-01-05 2011-01-05 Nouveau procede de synthese de l'agomelatine
PCT/FR2012/000004 WO2012093225A1 (fr) 2011-01-05 2012-01-04 Nouveau procede de synthese de l'agomelatine

Publications (2)

Publication Number Publication Date
CU20130087A7 CU20130087A7 (es) 2013-08-29
CU24291B1 true CU24291B1 (es) 2017-12-08

Family

ID=44121614

Family Applications (1)

Application Number Title Priority Date Filing Date
CUP2013000087A CU24291B1 (es) 2011-01-05 2012-01-04 Nuevo procedimiento de síntesis de la agomelatina

Country Status (42)

Country Link
US (1) US8871975B2 (ar)
EP (1) EP2661423B1 (ar)
JP (1) JP5837615B2 (ar)
KR (1) KR101544129B1 (ar)
CN (1) CN103298779B (ar)
AP (1) AP3399A (ar)
AR (1) AR084779A1 (ar)
AU (1) AU2012204817B2 (ar)
BR (1) BR112013017264A2 (ar)
CA (1) CA2823584C (ar)
CL (1) CL2013001881A1 (ar)
CO (1) CO6731102A2 (ar)
CR (1) CR20130300A (ar)
CU (1) CU24291B1 (ar)
CY (1) CY1116366T1 (ar)
DK (1) DK2661423T3 (ar)
EA (1) EA024126B1 (ar)
ES (1) ES2539173T3 (ar)
FR (1) FR2970001B1 (ar)
GE (1) GEP201606576B (ar)
GT (1) GT201300176A (ar)
HR (1) HRP20150504T1 (ar)
IL (1) IL227282A (ar)
JO (1) JO3085B1 (ar)
ME (1) ME02109B (ar)
MX (1) MX2013007838A (ar)
MY (1) MY162973A (ar)
NI (1) NI201300061A (ar)
PE (1) PE20140169A1 (ar)
PH (1) PH12013501279A1 (ar)
PL (1) PL2661423T3 (ar)
PT (1) PT2661423E (ar)
RS (1) RS53958B1 (ar)
SA (1) SA112330135B1 (ar)
SG (1) SG191191A1 (ar)
SI (1) SI2661423T1 (ar)
TN (1) TN2013000273A1 (ar)
TW (1) TWI534127B (ar)
UA (1) UA104123C2 (ar)
UY (1) UY33847A (ar)
WO (1) WO2012093225A1 (ar)
ZA (1) ZA201305026B (ar)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2658818B1 (fr) * 1990-02-27 1993-12-31 Adir Cie Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2866335B1 (fr) * 2004-02-13 2006-05-26 Servier Lab Nouveau procede de synthese de l'agomelatine
FR2934859B1 (fr) * 2008-08-05 2010-08-13 Servier Lab Nouveau procede de synthese de l'agomelatine

Also Published As

Publication number Publication date
PE20140169A1 (es) 2014-02-15
CA2823584C (fr) 2015-09-01
JP2014509308A (ja) 2014-04-17
WO2012093225A1 (fr) 2012-07-12
RS53958B1 (sr) 2015-08-31
IL227282A (en) 2015-06-30
ES2539173T3 (es) 2015-06-26
TN2013000273A1 (fr) 2014-11-10
CN103298779B (zh) 2015-01-28
CA2823584A1 (fr) 2012-07-12
EP2661423B1 (fr) 2015-03-11
HK1189217A1 (en) 2014-05-30
SI2661423T1 (sl) 2015-10-30
UA104123C2 (uk) 2013-12-25
AP2013007024A0 (en) 2013-07-31
GT201300176A (es) 2014-12-30
PL2661423T3 (pl) 2015-07-31
BR112013017264A2 (pt) 2016-10-25
EP2661423A1 (fr) 2013-11-13
NI201300061A (es) 2013-12-11
JO3085B1 (ar) 2017-03-15
CO6731102A2 (es) 2013-08-15
AP3399A (en) 2015-08-31
PH12013501279A1 (en) 2021-06-02
MX2013007838A (es) 2013-09-06
ZA201305026B (en) 2014-03-26
US8871975B2 (en) 2014-10-28
CU20130087A7 (es) 2013-08-29
DK2661423T3 (da) 2015-06-22
US20130289308A1 (en) 2013-10-31
KR101544129B1 (ko) 2015-08-12
NZ612163A (en) 2015-09-25
SA112330135B1 (ar) 2014-08-31
IL227282A0 (en) 2013-09-30
MY162973A (en) 2017-07-31
AR084779A1 (es) 2013-06-26
FR2970001B1 (fr) 2013-01-04
UY33847A (es) 2012-07-31
CN103298779A (zh) 2013-09-11
EA024126B1 (ru) 2016-08-31
PT2661423E (pt) 2015-05-18
AU2012204817A1 (en) 2013-07-11
TW201309624A (zh) 2013-03-01
CY1116366T1 (el) 2017-02-08
CL2013001881A1 (es) 2013-12-06
FR2970001A1 (fr) 2012-07-06
KR20130115344A (ko) 2013-10-21
EA201300793A1 (ru) 2013-12-30
ME02109B (me) 2015-10-20
CR20130300A (es) 2013-08-09
TWI534127B (zh) 2016-05-21
AU2012204817B2 (en) 2015-08-27
GEP201606576B (en) 2016-11-25
SG191191A1 (en) 2013-07-31
HRP20150504T1 (hr) 2015-06-05
JP5837615B2 (ja) 2015-12-24

Similar Documents

Publication Publication Date Title
CU20090139A7 (es) Nuevo procedimiento de síntesis de agomelatina
CU20090137A7 (es) Nuevo procedimiento de síntesis de la agomelatina
CR20130539A (es) Triazolopiridinas
UY34445A (es) Nuevos compuestos inhibidores de la fosfodiesterasa del tipo 10a
CR20140468A (es) Inhibidores de diacilglicerol aciltransferasa 2
CR20120295A (es) Triazolopiridinas
CR20120637A (es) Triazolopiridinas sustituidas
ECSP13012366A (es) Procedimiento de preparación de la sal de l-arginina de perindoprilo
ECSP13012914A (es) Síntesis de derivados de 2-carboxamida-cicloamino-urea
CY1121116T1 (el) Νεα μεθοδος για την συνθεση αγομελατινης
MX386134B (es) Proceso para la preparación de 5-fluoro-1h-pirazoles.
CU20090131A7 (es) Nuevo proceso de síntesis industrial de agomelatina
CR10952A (es) Nuevo procedimiento de obtencion de la forma cristalina v de la agomelatina
ECSP13012735A (es) Nuevo procedimiento de síntesis de la agomelatina
UY33905A (es) Inhibidores de la catepsina c
MX2014002378A (es) Proceso para la preparacion de (r)-2-acetamido-n-bencil-3-metoxipr opionamida e intermediarios de la misma.
CU20130087A7 (es) Nuevo procedimiento de síntesis de la agomelatina
CU20090138A7 (es) Nuevo procedimiento de obtención de la forma cristalina v de la agomelatina